ORG Activators
The chemical class known as BGLAP activators encompasses a diverse range of compounds that exert their influence on BGLAP expression and activation through various signaling pathways and cellular processes. These compounds play a crucial role in regulating osteoblastic activity and bone mineralization. One key group includes lithium chloride and lithium carbonate, which act as GSK-3β inhibitors, thereby modulating the Wnt/β-catenin pathway. This modulation results in enhanced BGLAP expression, promoting osteoblastic differentiation and matrix mineralization.
Furthermore, cyclic AMP inducers such as forskolin and dibutyryl cAMP (db-cAMP) activate BGLAP by stimulating the cAMP/PKA pathway, fostering an osteogenic microenvironment. Vitamin D analogs like 1,25-dihydroxyvitamin D3 and calcitriol directly activate BGLAP through their receptors, promoting osteoblast differentiation and supporting mineralization. Additionally, sodium fluoride inhibits protein tyrosine phosphatases, sustaining phosphorylation events that indirectly activate BGLAP by enhancing osteoblastic activities. The aryl hydrocarbon receptor (AhR) agonist, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), directly activates BGLAP by interacting with AhR, inducing osteoblastic differentiation. Prostaglandin E2 (PGE2) stimulates BGLAP via EP receptors, activating cAMP signaling and promoting osteoblast differentiation. These chemicals collectively contribute to the intricate regulation of BGLAP, playing vital roles in the modulation of bone formation and mineralization processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride enhances BGLAP expression via GSK-3β inhibition, leading to increased osteoblastic activity. This compound modulates the Wnt/β-catenin pathway, promoting BGLAP transcription and subsequent protein activation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, a cyclic AMP inducer, stimulates BGLAP expression by activating PKA. This triggers downstream signaling cascades, enhancing osteoblastic differentiation and supporting bone mineralization. It indirectly activates BGLAP via the cAMP/PKA pathway. | ||||||
Parathyroid hormone fragment (1-34) | 52232-67-4 | sc-487943 | 100 µg | $185.00 | ||
PTH stimulates BGLAP through the PTH/PTHrP receptor, activating cAMP signaling. This enhances osteoblast differentiation and calcium influx, indirectly activating BGLAP by fostering an osteogenic microenvironment within bone tissue. | ||||||
Sodium Fluoride | 7681-49-4 | sc-24988A sc-24988 sc-24988B | 5 g 100 g 500 g | $40.00 $46.00 $100.00 | 26 | |
Sodium fluoride activates BGLAP expression by inhibiting protein tyrosine phosphatases. This leads to sustained phosphorylation events, promoting osteoblastic differentiation and extracellular matrix mineralization, indirectly activating BGLAP. | ||||||
1α,25-Dihydroxyvitamin D3 | 32222-06-3 | sc-202877B sc-202877A sc-202877C sc-202877D sc-202877 | 50 µg 1 mg 5 mg 10 mg 100 µg | $220.00 $645.00 $1000.00 $1500.00 $440.00 | 32 | |
1,25-Dihydroxyvitamin D3, an active form of vitamin D, directly activates BGLAP by binding to its receptor. This induces osteoblast differentiation and enhances mineralization. The vitamin D receptor-mediated activation promotes BGLAP expression and functionality. | ||||||
β-Glycerophosphate disodium salt | 819-83-0 | sc-220452 sc-220452A sc-220452B sc-220452C sc-220452D sc-220452E | 25 g 100 g 500 g 1 kg 3 kg 6 kg | $63.00 $119.00 $442.00 $738.00 $2091.00 $3652.00 | 43 | |
Beta-glycerophosphate acts as a phosphate donor, supporting osteoblastic mineralization. By providing a substrate for mineral deposition, it indirectly activates BGLAP by fostering an environment conducive to extracellular matrix mineralization. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
PGE2 stimulates BGLAP through EP receptors, activating cAMP signaling. This promotes osteoblast differentiation and matrix mineralization, indirectly supporting BGLAP activation by fostering a favorable cellular environment for osteogenesis. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid directly activates BGLAP by binding to its receptor. This induction promotes osteoblast differentiation and mineralization, highlighting its role in regulating BGLAP expression and supporting its activation in bone-forming processes. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Db-cAMP, a cAMP analog, stimulates BGLAP expression by activating PKA. This induces osteoblastic differentiation and promotes matrix mineralization, indirectly supporting BGLAP activation by enhancing the cAMP/PKA signaling pathway. | ||||||